About Donald Olds
Form D filings for Response Pharmaceuticals in 2024 list Donald Olds as director.
Donald Olds first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Donald Olds in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Donald Olds works with at each company, as listed on that company's latest Form D.
Response Pharmaceuticals, Inc. · Form D, Jun 28, 2024
MB
Michael Berendt
Director
EK
Eric Keller
President and CEO, director